type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

Tech Marches On, While Humanity Drags Its Feet

John Nosta -
I thought it would be fun to look back at some of my predictions for health tech from almost a decade ago in Forbes....

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

Richard Hatzfeld -
This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Science Duuude -
The evolution of Hydroxychloroquine. From malarial treatment to snake oil for curing Covid. America's love affair with quackery and snake oil explored

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories